Corbus Pharmaceuticals Holding Stock Price on November 14, 2024
| CRBP Stock | USD 17.47 0.74 4.42% |
Below is the normalized historical share price chart for Corbus Pharmaceuticals Holding extending back to October 27, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Corbus Pharmaceuticals stands at 17.47, as last reported on the 25th of November, with the highest price reaching 17.75 and the lowest price hitting 16.50 during the day.
If you're considering investing in Corbus Stock, it is important to understand the factors that can impact its price. Corbus Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14% return per unit of risk over the last 3 months. Corbus Pharmaceuticals Holding exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Corbus Pharmaceuticals' Standard Deviation of 8.76, mean deviation of 4.03, and Risk Adjusted Performance of (0.1) to double-check the risk estimate we provide.
At this time, Corbus Pharmaceuticals' Common Stock Total Equity is relatively stable compared to the past year. As of 11/25/2024, Liabilities And Stockholders Equity is likely to grow to about 50.5 M, while Other Stockholder Equity is likely to drop slightly above 216.4 M. . As of 11/25/2024, Price Earnings To Growth Ratio is likely to grow to 0.03, while Price To Sales Ratio is likely to drop 93.82. Corbus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of November 2014 | 200 Day MA 38.8067 | 50 Day MA 20.9236 | Beta 2.565 |
Corbus |
Sharpe Ratio = -0.1363
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CRBP |
Estimated Market Risk
| 8.89 actual daily | 79 79% of assets are less volatile |
Expected Return
| -1.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Corbus Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Corbus Pharmaceuticals by adding Corbus Pharmaceuticals to a well-diversified portfolio.
Price Book 1.4138 | Enterprise Value Ebitda 0.1697 | Price Sales 163.3187 | Shares Float 8.5 M | Wall Street Target Price 59.5 |
Related Headline
Cue Biopharma Headline on 14th of November 2024
Cue BiopharmaReports Third Quarter 2024 Financial Results an... by globenewswire.com
BOSTON, Nov. 14, 2024 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of...
Corbus Pharmaceuticals Valuation on November 14, 2024
It is possible to determine the worth of Corbus Pharmaceuticals on a given historical date. On November 14, 2024 Corbus was worth 18.4 at the beginning of the trading date compared to the closed value of 17.55. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Corbus Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Corbus Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Corbus Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Corbus Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 17.77 | 18.66 | 17.55 | 18.17 | 384,093 | |
11/14/2024 | 18.40 | 18.40 | 17.50 | 17.55 | 260,006 |
| 17.64 | 17.64 | 16.46 | 16.61 | 296,274 |
| Backtest Corbus Pharmaceuticals | | | Corbus Pharmaceuticals History | | | Corbus Pharmaceuticals Valuation | Previous | Next |
Corbus Pharmaceuticals Trading Date Momentum on November 14, 2024
| On November 15 2024 Corbus Pharmaceuticals Holding was traded for 16.61 at the closing time. The top price for the day was 17.64 and the lowest listed price was 16.46 . The trading volume for the day was 296.3 K. The trading history from November 15, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 5.36% . The overall trading delta against the current closing price is 4.56% . |
Corbus Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Corbus Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Corbus Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Corbus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Corbus Pharmaceuticals Stock history
Corbus Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Corbus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Corbus Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Corbus Pharmaceuticals stock prices may prove useful in developing a viable investing in Corbus Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.3 M | 2.9 M | |
| Net Loss | -38.1 M | -40 M |
Corbus Pharmaceuticals Stock Technical Analysis
Corbus Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Corbus Pharmaceuticals Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Corbus Pharmaceuticals Holding cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Corbus Pharmaceuticals November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Corbus Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Corbus Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Corbus Pharmaceuticals stock market strength indicators, traders can identify Corbus Pharmaceuticals Holding entry and exit signals to maximize returns
Corbus Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Corbus Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Corbus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Corbus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (1.43) | |||
| Total Risk Alpha | (2.62) | |||
| Treynor Ratio | (0.83) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Corbus Stock Analysis
When running Corbus Pharmaceuticals' price analysis, check to measure Corbus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corbus Pharmaceuticals is operating at the current time. Most of Corbus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corbus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corbus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corbus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.